News

A new generation, high resolution mass spectrometer (MS) is designed to give proteomics, metabolomics, biopharmaceutical characterization and small-molecule scientists the analytical performance required for research and high-throughput analyses. The new system will help drive discovery and identification with increased...

Leading pharmaceutical outsourcing partner, the Wasdell Group (Wasdell), has been granted an Investigational Medicinal Product (IMP) licence by the Health Products Regulatory Authority (HPRA) at its Dundalk, Ireland facility. This licence enables Wasdell to expand the facility’s services to include...

Truking is celebrating its 20th anniversary with the ground-breaking dig for a new construction project. The pharmaceutical machinery manufacturer is extending its industrial park in the central Chinese city of Changsha, where eight new buildings will go up within...

Albumedix Ltd. , the world leader in recombinant human albumin (rAlb), announced its succession plan as Peter Rosholm, after 13 years leading the company, has decided to step down as CEO and handover the company’s leadership. Peter’ successor as...

A look at vital figures makes it clear that Vetter is a very successful, globally active Contract Development and Manufacturing Organization (CDMO). Over the last ten years, the company has more than doubled its annual sales revenues to approximately...

GlaxoSmithKline and Samsung Biologics have entered into a partnership to provide GSK with additional capacity to manufacture and supply GSK’s innovative biopharmaceutical therapies. Under the terms of the agreement, Samsung Biologics will provide GSK with additional capacity for large-scale biopharmaceutical...

Roche announced positive topline results from the phase III Archway study, evaluating Port Delivery System with ranibizumab (PDS) in people living with neovascular or “wet” age-related macular degeneration (nAMD). PDS is a permanent refillable eye implant, approximately the size...